These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 17414320

  • 1. IL-2 and IL-15 each mediate de novo induction of FOXP3 expression in human tumor antigen-specific CD8 T cells.
    Ahmadzadeh M, Antony PA, Rosenberg SA.
    J Immunother; 2007 Apr; 30(3):294-302. PubMed ID: 17414320
    [Abstract] [Full Text] [Related]

  • 2. IL-15 acts as a potent inducer of CD4(+)CD25(hi) cells expressing FOXP3.
    Imamichi H, Sereti I, Lane HC.
    Eur J Immunol; 2008 Jun; 38(6):1621-30. PubMed ID: 18493981
    [Abstract] [Full Text] [Related]

  • 3. IL-2 promotes the function of memory-like autoregulatory CD8+ T cells but suppresses their development via FoxP3+ Treg cells.
    Shameli A, Yamanouchi J, Tsai S, Yang Y, Clemente-Casares X, Moore A, Serra P, Santamaria P.
    Eur J Immunol; 2013 Feb; 43(2):394-403. PubMed ID: 23180662
    [Abstract] [Full Text] [Related]

  • 4. Activation of naive and memory T cells by interleukin-15.
    Kanegane H, Tosato G.
    Blood; 1996 Jul 01; 88(1):230-5. PubMed ID: 8704178
    [Abstract] [Full Text] [Related]

  • 5. The maintenance of human CD4+ CD25+ regulatory T cell function: IL-2, IL-4, IL-7 and IL-15 preserve optimal suppressive potency in vitro.
    Yates J, Rovis F, Mitchell P, Afzali B, Tsang J, Garin M, Lechler RI, Lombardi G, Garden OA.
    Int Immunol; 2007 Jun 01; 19(6):785-99. PubMed ID: 17545278
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Tumor-reactive CD8+ early effector T cells identified at tumor site in primary and metastatic melanoma.
    Anichini A, Molla A, Vegetti C, Bersani I, Zappasodi R, Arienti F, Ravagnani F, Maurichi A, Patuzzo R, Santinami M, Pircher H, Di Nicola M, Mortarini R.
    Cancer Res; 2010 Nov 01; 70(21):8378-87. PubMed ID: 20861189
    [Abstract] [Full Text] [Related]

  • 8. IL-15 augments TCR-induced CD4+ T cell expansion in vitro by inhibiting the suppressive function of CD25 High CD4+ T cells.
    Van Belle TL, Dooms H, Boonefaes T, Wei XQ, Leclercq G, Grooten J.
    PLoS One; 2012 Nov 01; 7(9):e45299. PubMed ID: 23028916
    [Abstract] [Full Text] [Related]

  • 9. Ex vivo expansion of human CD8+ T cells using autologous CD4+ T cell help.
    Butler MO, Imataki O, Yamashita Y, Tanaka M, Ansén S, Berezovskaya A, Metzler G, Milstein MI, Mooney MM, Murray AP, Mano H, Nadler LM, Hirano N.
    PLoS One; 2012 Nov 01; 7(1):e30229. PubMed ID: 22279573
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Unique phenotype of human tonsillar and in vitro-induced FOXP3+CD8+ T cells.
    Siegmund K, Rückert B, Ouaked N, Bürgler S, Speiser A, Akdis CA, Schmidt-Weber CB.
    J Immunol; 2009 Feb 15; 182(4):2124-30. PubMed ID: 19201865
    [Abstract] [Full Text] [Related]

  • 12. Differential responsiveness to IL-2, IL-7, and IL-15 common receptor gamma chain cytokines by antigen-specific peripheral blood naive or memory cytotoxic CD8+ T cells from healthy donors and melanoma patients.
    Rosenthal R, Groeper C, Bracci L, Adamina M, Feder-Mengus C, Zajac P, Iezzi G, Bolli M, Weber WP, Frey DM, von Holzen U, Oertli D, Heberer M, Spagnoli GC.
    J Immunother; 2009 Apr 15; 32(3):252-61. PubMed ID: 19242375
    [Abstract] [Full Text] [Related]

  • 13. Comparative dose-responses of recombinant human IL-2 and IL-7 on STAT5 phosphorylation in CD4+FOXP3- cells versus regulatory T cells: a whole blood perspective.
    Dupont G, Demaret J, Venet F, Malergue F, Malcus C, Poitevin-Later F, Morel J, Monneret G.
    Cytokine; 2014 Sep 15; 69(1):146-9. PubMed ID: 24947990
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Skin tumor responsiveness to interleukin-2 treatment and CD8 Foxp3+ T cell expansion in an immunocompetent mouse model.
    Foureau DM, McKillop IH, Jones CP, Amin A, White RL, Salo JC.
    Cancer Immunol Immunother; 2011 Sep 15; 60(9):1347-56. PubMed ID: 21638127
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Ex vivo expansion of dendritic-cell-activated antigen-specific CD4+ T cells with anti-CD3/CD28, interleukin-7, and interleukin-15: potential for adoptive T cell immunotherapy.
    Chen HW, Liao CH, Ying C, Chang CJ, Lin CM.
    Clin Immunol; 2006 Apr 15; 119(1):21-31. PubMed ID: 16406844
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Plasmodium falciparum-mediated induction of human CD25Foxp3 CD4 T cells is independent of direct TCR stimulation and requires IL-2, IL-10 and TGFbeta.
    Scholzen A, Mittag D, Rogerson SJ, Cooke BM, Plebanski M.
    PLoS Pathog; 2009 Aug 15; 5(8):e1000543. PubMed ID: 19680449
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.